Targeting the cytoskeleton with an FDA approved drug to promote recovery after spinal cord injury.

Targeting the cytoskeleton with an FDA approved drug to promote recovery after spinal cord injury. Exp Neurol. 2018 May 09;: Authors: Vagnozzi AN, Silver J PMID: 29752944 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29752944?dopt=Abstract

Source: Experimental Neurology - May 9, 2018 Category: Neurology Authors: Vagnozzi AN, Silver J Tags: Exp Neurol Source Type: research

More News: Brain | Neurology | Spinal Cord Injury